Immunotherapy has transformed cancer treatment, yet many tumors remain stubbornly resistant to its effects. Among the most challenging are "cold tumors," including ovarian, breast, and prostate ...

Immunotherapy has transformed cancer treatment, yet many tumors remain stubbornly resistant to its effects. Among the most challenging are "cold tumors," including ovarian, breast, and prostate ...

Natural killer (NK) cells are the bodyguards of our immune system. As a first line of defense, they destroy invading pathogens, foreign bodies, and infected cells in early stages, thereby preventing ...

The strongest results appeared when the enhanced natural killer cells were combined with cetuximab, a monoclonal antibody ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the release of toxic granules—microscopic packages that destroy virus-infected or ...

Modifications to a type of immune cell programmed to recognize and kill cancerous tumors could make them even more effective assassins. Researchers from the Massachusetts Institute of Technology (MIT) ...

Researchers have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and effectively attack them. The ...

“While recent single-cell multiomics studies and CRISPR screens in murine NK cells have expanded our understanding, actionable genomic targets in primary human NK cells have remained largely ...

Cancer remains one of the hardest diseases to treat because cancer cells come from the body’s own cells and can find ways to escape treatment. Chemotherapy, radiation, targeted drugs and newer ...